Krystal Biotech (KRYS) Cost of Revenue (2023 - 2026)
Krystal Biotech's Cost of Revenue was $7.56 million in Q3 2026, up 77.2% from $4.26 million a year earlier and up 17.4% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Cost of Revenue (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Krystal Biotech's Cost of Revenue was $26.91 million through Sep 30, 2026, up 25.7% year-over-year; for FY2025, it was $23.05 million, up 14.9% from FY2024.
- In earlier years, Cost of Revenue was $20.06 million in FY2024 (+548.4%) and $3.09 million in FY2023.
- The Q3 2026 figure marks the highest quarterly Cost of Revenue in data going back to Q3 2023.
- Compared with a year earlier, Cost of Revenue was higher in six of the last eight quarters, with growth averaging 36.2%.
- The best year-over-year quarter for Cost of Revenue over five years was Q1 2025 (growth of 107.9%); the worst was Q3 2025 (a decline of 36.2%).
- Per Business Quant data, KRYS's Cost of Revenue in the three quarters before Q3 2026 was $6.44 million (Q2 2026), $6.32 million (Q1 2026) and $6.59 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 7.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.56 Mn |
| Jun 30, 2026 | 6.44 Mn |
| Mar 31, 2026 | 6.32 Mn |
| Dec 31, 2025 | 6.59 Mn |
| Sep 30, 2025 | 4.26 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 5.03 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 6.01 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Sep 30, 2023 | 223,000.00 |
API Access
Krystal Biotech Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();